Na
Not verified

Natera, Inc.

What we write about

BiotechnologyHealthIndustriaMedicine - variousOncology
08/05/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
Health
Biotechnology
Scienza
Oncology
Natera Reports First Quarter 2025 Financial Results
1.00
08/05/2025
Eventi
Fairs
Industria
Oncology
Health
Biotechnology
Scienza
Medicine - various
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress
1.00
05/05/2025
Industria
Scienza
Biotechnology
Medicine - various
Health
University
School / Education
Oncology
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
1.00
01/05/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
Finance
stock market
Biotechnology
Health
Oncology
Natera to Report its First Quarter Results on May 8, 2025
1.00
24/04/2025
Industria
Health
Sanità
Communication
Oncology
Scienza
Biotechnology
Fitness / Wellness
Windows / Shopping
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
1.00
22/04/2025
Oncology
Health
Biotechnology
Medicine - various
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
1.00
25/03/2025
Industria
Scienza
Cardiology
Biotechnology
Medicine - various
Health
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
1.00
10/03/2025
Labour market
Industria
Scienza
Sanità
Biotechnology
Medicine - various
Health
Pharmaceuticals
Oncology
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
1.00

Contact details

Social Media

Followers
0
Compatibility
0